Paediatric-type diffuse low-grade gliomas: a clinically and biologically distinct group of tumours with a favourable outcome.
angiocentric glioma
diffuse astrocytoma altered by MYB or MYBL1
diffuse low-grade glioma with an altered MAPK pathway
low-grade polymorphic juvenile neuroepithelial tumour
paediatric-type diffuse low grade glioma
Journal
Pathologica
ISSN: 1591-951X
Titre abrégé: Pathologica
Pays: Italy
ID NLM: 0401123
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
03
11
2022
accepted:
12
11
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
22
12
2022
Statut:
ppublish
Résumé
The WHO 2021 classification of central nervous system cancers distinguishes diffuse gliomas that arise in adults (referred to as the "adult type") and those that arise in children (defined as "paediatric") based on clinical and molecular characteristics."). However, paediatric-type gliomas may occasionally be present in younger adults and occasionally adult-type gliomas may occur in children. Diffuse low-grade paediatric glioma includes diffuse astrocytoma altered by MYB or MYBL1, low-grade polymorphic juvenile neuroepithelial tumour, angiocentric glioma, and diffuse low-grade glioma with an altered MAPK pathway. Here, we examine these newly recognised entities according to WHO diagnostic criteria and propose an integrated diagnostic approach that can be used to separate these clinically and biologically distinct tumor groups.
Identifiants
pubmed: 36534420
doi: 10.32074/1591-951X-828
pmc: PMC9763978
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
410-421Informations de copyright
Copyright © 2022 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.
Références
Acta Neuropathol. 2004 May;107(5):381-8
pubmed: 15034726
Acta Neuropathol Commun. 2020 Mar 9;8(1):27
pubmed: 32151273
Acta Neuropathol. 2020 Jan;139(1):193-209
pubmed: 31563982
Endocr Rev. 2001 Apr;22(2):153-83
pubmed: 11294822
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8188-93
pubmed: 23633565
Genes (Basel). 2022 Mar 31;13(4):
pubmed: 35456430
Acta Neuropathol. 2021 Jan;141(1):123-125
pubmed: 33226472
Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96
pubmed: 33123732
Neuroradiology. 2019 Nov;61(11):1327-1332
pubmed: 31396664
World Neurosurg. 2019 Dec;132:347-355
pubmed: 31520766
Acta Neuropathol. 2017 Oct;134(4):667-669
pubmed: 28803398
Am J Surg Pathol. 2007 Nov;31(11):1709-18
pubmed: 18059228
Biochem J. 2005 Dec 1;392(Pt 2):249-61
pubmed: 16293107
Brain Pathol. 2005 Oct;15(4):281-6
pubmed: 16389940
Acta Neuropathol. 2014 Jul;128(1):39-54
pubmed: 24858213
Cell Res. 2002 Mar;12(1):9-18
pubmed: 11942415
Cancer Cell. 2020 Apr 13;37(4):569-583.e5
pubmed: 32289278
Acta Neuropathol. 2017 Mar;133(3):417-429
pubmed: 27812792
J Neuroimaging. 2022 May;32(3):389-399
pubmed: 35201652
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Acta Neurol Belg. 2020 Jun;120(3):729-732
pubmed: 31754999
Exp Ther Med. 2020 Mar;19(3):1997-2007
pubmed: 32104259
J Neuropathol Exp Neurol. 2005 Oct;64(10):875-81
pubmed: 16215459
Acta Neuropathol. 2019 Apr;137(4):683-687
pubmed: 30848347
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Acta Neuropathol Commun. 2020 Aug 18;8(1):139
pubmed: 32811569
Acta Neuropathol. 2016 Jun;131(6):833-45
pubmed: 26810070